BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 12111309)

  • 21. Anti-Hu antibodies in patients with small-cell lung cancer: association with complete response to therapy and improved survival.
    Graus F; Dalmou J; Reñé R; Tora M; Malats N; Verschuuren JJ; Cardenal F; Viñolas N; Garcia del Muro J; Vadell C; Mason WP; Rosell R; Posner JB; Real FX
    J Clin Oncol; 1997 Aug; 15(8):2866-72. PubMed ID: 9256130
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Neurologic paraneoplastic syndromes and anti-neuronal antibodies].
    Mygland A
    Tidsskr Nor Laegeforen; 1996 Jan; 116(3):361-5. PubMed ID: 8638263
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Paraneoplastic subacute sensory Denny-Brown neuronopathy or anti-Hu syndrome: a classical paraneoplastic syndrome].
    Lövblad KO; Boucraut J; Steck AJ
    Rev Med Suisse Romande; 1995 May; 115(5):421-6. PubMed ID: 7770690
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Limbic encephalitis and small cell lung cancer. Clinical and immunological features.
    Alamowitch S; Graus F; Uchuya M; Reñé R; Bescansa E; Delattre JY
    Brain; 1997 Jun; 120 ( Pt 6)():923-8. PubMed ID: 9217677
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Isolated frontal disequilibrium as presenting form of anti-Hu paraneoplastic encephalomyelitis.
    Compta Y; Valldeoriola F; Urra X; Gómez-Ansón B; Rami L; Tolosa E; Graus F
    Mov Disord; 2007 Apr; 22(5):736-8. PubMed ID: 17266086
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Three patients with a paraneoplastic neurological syndrome: the significance of paraneoplastic antibodies].
    Smitt PA; Polman SK; de Beukelaar JW; Enting RH; van den Bent MJ; Bromberg JE; Kros JM; Hooijkaas H
    Ned Tijdschr Geneeskd; 2007 Apr; 151(15):874-80. PubMed ID: 17472120
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pathogenesis of paraneoplastic neurological syndromes].
    Tanaka K
    Brain Nerve; 2010 Apr; 62(4):309-18. PubMed ID: 20420170
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Neurological syndromes, encephalitis].
    Yamamoto T; Tsuji S
    Gan To Kagaku Ryoho; 2010 Jun; 37(6):995-1005. PubMed ID: 20567100
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Paraneoplastic chronic demyelinating neuropathy and Lambert-Eaton myasthenic syndrome associated with multiple anti-neural antibodies and small-cell lung cancer.
    Rozsa C; Vincent A; Aranyi Z; Kovacs GG; Komoly S; Illes Z
    Ideggyogy Sz; 2008 Sep; 61(9-10):325-8. PubMed ID: 18841652
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Paraneoplastic neurological disorders.
    Blaes F; Tschernatsch M
    Expert Rev Neurother; 2010 Oct; 10(10):1559-68. PubMed ID: 20925471
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Onco-neural antibodies and tumour type determine survival and neurological symptoms in paraneoplastic neurological syndromes with Hu or CV2/CRMP5 antibodies.
    Honnorat J; Cartalat-Carel S; Ricard D; Camdessanche JP; Carpentier AF; Rogemond V; Chapuis F; Aguera M; Decullier E; Duchemin AM; Graus F; Antoine JC
    J Neurol Neurosurg Psychiatry; 2009 Apr; 80(4):412-6. PubMed ID: 18931014
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Small cell lung cancer and anti-Hu syndrome].
    Prim N; Mennecier B; Behr C; Fraisse P; Echaniz-Laguna A; Tranchant C; Quoix E
    Rev Mal Respir; 2010 Mar; 27(3):261-5. PubMed ID: 20359620
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-SOX1 antibodies in patients with paraneoplastic and non-paraneoplastic neuropathy.
    Tschernatsch M; Singh P; Gross O; Gerriets T; Kneifel N; Probst C; Malas S; Kaps M; Blaes F
    J Neuroimmunol; 2010 Sep; 226(1-2):177-80. PubMed ID: 20701982
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Autoimmunity and paraneoplastic neurologic syndromes].
    Delattre JY; Davila L; Vega F; Poisson M
    Rev Neurol (Paris); 1991; 147(8-9):549-56. PubMed ID: 1962063
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DNA vaccination with HuD inhibits growth of a neuroblastoma in mice.
    Carpentier AF; Rosenfeld MR; Delattre JY; Whalen RG; Posner JB; Dalmau J
    Clin Cancer Res; 1998 Nov; 4(11):2819-24. PubMed ID: 9829748
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Paraneoplastic neurological syndromes: diagnosis and treatment.
    Graus F; Dalmau J
    Curr Opin Neurol; 2007 Dec; 20(6):732-7. PubMed ID: 17992098
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association.
    Saiz A; Blanco Y; Sabater L; González F; Bataller L; Casamitjana R; Ramió-Torrentà L; Graus F
    Brain; 2008 Oct; 131(Pt 10):2553-63. PubMed ID: 18687732
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Paraneoplastic cerebellar degeneration].
    Chabriat H; Chen QM; Poisson M; Delattre JY
    Rev Neurol (Paris); 1994; 150(2):105-14. PubMed ID: 7863150
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Paraneoplastic cerebellar degeneration].
    Sakai K
    Brain Nerve; 2010 Apr; 62(4):357-64. PubMed ID: 20420175
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical and pathological advances on central nervous system paraneoplastic syndromes.
    Graus F; René R
    Rev Neurol (Paris); 1992; 148(6-7):496-501. PubMed ID: 1448670
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.